{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:43:28Z","timestamp":1786167808582,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-026-02040-z","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:40:25Z","timestamp":1782452425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Relapsing Seronegative Immune-Mediated Cerebellar Ataxia with Evolving Intrathecal Immune Activation and Rituximab Consolidation in a Toddler: A Case Report"],"prefix":"10.1007","volume":"25","author":[{"given":"Panhui","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengjiu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"1","key":"2040_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/1570159X16666180917105033","volume":"17","author":"H Mitoma","year":"2019","unstructured":"Mitoma H, Manto M, Hampe CS. Immune-mediated cerebellar ataxias: practical guidelines and therapeutic challenges. Curr Neuropharmacol. 2019;17(1):33\u201358. https:\/\/doi.org\/10.2174\/1570159X16666180917105033.","journal-title":"Curr Neuropharmacol"},{"issue":"8","key":"2040_CR2","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1136\/archdischild-2018-315487","volume":"104","author":"G Garone","year":"2019","unstructured":"Garone G, Reale A, Vanacore N, Parisi P, Bondone C, Suppiej A, et al. Acute ataxia in paediatric emergency departments: a multicentre Italian study. Arch Dis Child. 2019;104(8):768\u201374. https:\/\/doi.org\/10.1136\/archdischild-2018-315487.","journal-title":"Arch Dis Child"},{"issue":"6","key":"2040_CR3","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/ana.410350607","volume":"35","author":"AM Connolly","year":"1994","unstructured":"Connolly AM, Dodson WE, Prensky AL, Rust RS. Course and outcome of acute cerebellar ataxia. Ann Neurol. 1994;35(6):673\u20139. https:\/\/doi.org\/10.1002\/ana.410350607.","journal-title":"Ann Neurol"},{"issue":"12","key":"2040_CR4","first-page":"1015","volume":"81","author":"A Visudtibhan","year":"1998","unstructured":"Visudtibhan A, Visudhiphan P, Chiemchanya S. Recurrent acute cerebellar ataxia of childhood following nonspecific respiratory tract infection. J Med Assoc Thai. 1998;81(12):1015\u20138.","journal-title":"J Med Assoc Thai"},{"issue":"1","key":"2040_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.braindev.2008.04.010","volume":"31","author":"K Ichikawa","year":"2009","unstructured":"Ichikawa K, Kikuchi M, Takeshita S, Nezu A. A case of chronic recurrent cerebellar ataxia responding to steroid therapy. Brain Dev. 2009;31(1):83\u20135. https:\/\/doi.org\/10.1016\/j.braindev.2008.04.010.","journal-title":"Brain Dev"},{"issue":"7","key":"2040_CR6","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.braindev.2009.07.009","volume":"32","author":"N Ishikawa","year":"2010","unstructured":"Ishikawa N, Kobayashi M. Recurrent acute cerebellar ataxia associated with anti-cardiolipin antibodies. Brain Dev. 2010;32(7):588\u201391. https:\/\/doi.org\/10.1016\/j.braindev.2009.07.009.","journal-title":"Brain Dev"},{"key":"2040_CR7","doi-asserted-by":"publisher","first-page":"1613558","DOI":"10.3389\/fped.2025.1613558","volume":"13","author":"Q Zhao","year":"2025","unstructured":"Zhao Q, Gao C, Wang L, Liu C, Sun S, Li B. Acute ataxia in children: etiological spectrum and clinical characteristics. Front Pediatr. 2025;13:1613558. https:\/\/doi.org\/10.3389\/fped.2025.1613558.","journal-title":"Front Pediatr"},{"issue":"4","key":"2040_CR8","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s12311-020-01132-8","volume":"19","author":"M Hadjivassiliou","year":"2020","unstructured":"Hadjivassiliou M, Graus F, Honnorat J, Jarius S, Titulaer M, Manto M, et al. Diagnostic criteria for primary autoimmune cerebellar ataxia: guidelines from an International Task Force on Immune-Mediated Cerebellar Ataxias. Cerebellum. 2020;19(4):605\u201310. https:\/\/doi.org\/10.1007\/s12311-020-01132-8.","journal-title":"Cerebellum"},{"issue":"11","key":"2040_CR9","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3390\/children12111513","volume":"12","author":"M Gontika","year":"2025","unstructured":"Gontika M, Tsimakidi C, Salamou E, Prattos T, Kallias N, Kilidireas C, et al. Seronegative immune-mediated cerebellar ataxia in children: autoimmune encephalitis spectrum disorder or a distinct entity? Child (Basel). 2025;12(11):1513. https:\/\/doi.org\/10.3390\/children12111513.","journal-title":"Child (Basel)"},{"issue":"4","key":"2040_CR10","doi-asserted-by":"publisher","first-page":"e0215410","DOI":"10.1371\/journal.pone.0215410","volume":"14","author":"H Hegen","year":"2019","unstructured":"Hegen H, Zinganell A, Auer M, Deisenhammer F. The clinical significance of single or double bands in cerebrospinal fluid isoelectric focusing: a retrospective study and systematic review. PLoS ONE. 2019;14(4):e0215410. https:\/\/doi.org\/10.1371\/journal.pone.0215410.","journal-title":"PLoS ONE"},{"issue":"11","key":"2040_CR11","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-Huebsch","year":"2006","unstructured":"Schmitz-Huebsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66(11):1717\u201320. https:\/\/doi.org\/10.1212\/01.wnl.0000219042.60538.92.","journal-title":"Neurology"},{"issue":"10","key":"2040_CR12","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/dmcn.13507","volume":"59","author":"TF Lawerman","year":"2017","unstructured":"Lawerman TF, Brandsma R, Burger H, Burgerhof JGM, Sival DA. Age-related reference values for the pediatric Scale for Assessment and Rating of Ataxia: a multicentre study. Dev Med Child Neurol. 2017;59(10):1077\u201382. https:\/\/doi.org\/10.1111\/dmcn.13507.","journal-title":"Dev Med Child Neurol"},{"key":"2040_CR13","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3389\/fnhum.2017.00605","volume":"11","author":"TF Lawerman","year":"2017","unstructured":"Lawerman TF, Brandsma R, Verbeek RJ, van der Hoeven JH, Lunsing RJ, Kremer HPH, et al. Construct validity and reliability of the SARA gait and posture sub-scale in early onset ataxia. Front Hum Neurosci. 2017;11:605. https:\/\/doi.org\/10.3389\/fnhum.2017.00605.","journal-title":"Front Hum Neurosci"},{"issue":"6","key":"2040_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1212\/CPJ.0000000000000659","volume":"9","author":"SL Barnes","year":"2019","unstructured":"Barnes SL, Brew BJ. Acute cerebellar ataxia after Epstein-Barr virus infection. Neurol Clin Pract. 2019;9(6):505\u20136. https:\/\/doi.org\/10.1212\/CPJ.0000000000000659.","journal-title":"Neurol Clin Pract"},{"key":"2040_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40673-015-0034-y","volume":"2","author":"H Mitoma","year":"2015","unstructured":"Mitoma H, Hadjivassiliou M, Honnorat J. Guidelines for treatment of immune-mediated cerebellar ataxias. Cerebellum Ataxias. 2015;2:14. https:\/\/doi.org\/10.1186\/s40673-015-0034-y.","journal-title":"Cerebellum Ataxias"},{"issue":"3","key":"2040_CR16","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s12311-013-0534-3","volume":"13","author":"V Planche","year":"2014","unstructured":"Planche V, Marques A, Ulla M, Ruivard M, Durif F. Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies. Cerebellum. 2014;13(3):318\u201322. https:\/\/doi.org\/10.1007\/s12311-013-0534-3.","journal-title":"Cerebellum"},{"issue":"3","key":"2040_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.pediatrneurol.2008.05.015","volume":"39","author":"WG Leen","year":"2008","unstructured":"Leen WG, Weemaes CM, Verbeek MM, Willemsen MA, Rotteveel JJ. Rituximab and intravenous immunoglobulins for relapsing postinfectious opsoclonus-myoclonus syndrome. Pediatr Neurol. 2008;39(3):213\u20137. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2008.05.015.","journal-title":"Pediatr Neurol"},{"issue":"3","key":"2040_CR18","doi-asserted-by":"publisher","first-page":"e1153","DOI":"10.1212\/NXI.0000000000001153","volume":"9","author":"T Rossor","year":"2022","unstructured":"Rossor T, Yeh EA, Khakoo Y, Angelini P, Hemingway C, Irani SR, et al. Diagnosis and management of opsoclonus-myoclonus-ataxia syndrome in children: an international perspective. Neurol Neuroimmunol Neuroinflamm. 2022;9(3):e1153. https:\/\/doi.org\/10.1212\/NXI.0000000000001153.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2040_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.pediatrneurol.2017.04.027","volume":"73","author":"MR Pranzatelli","year":"2017","unstructured":"Pranzatelli MR, Tate ED. Dexamethasone, intravenous immunoglobulin, and rituximab combination immunotherapy for pediatric opsoclonus-myoclonus syndrome. Pediatr Neurol. 2017;73:48\u201356. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2017.04.027.","journal-title":"Pediatr Neurol"},{"key":"2040_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13052-025-01875-2","volume":"51","author":"F He","year":"2025","unstructured":"He F, Kessi M, Zhang C, Peng J, Yin F, Yang L. The utilization of the multimodal immunotherapy for the opsoclonus-myoclonus syndrome can reduce relapses and permanent neurological sequelae. Ital J Pediatr. 2025;51:33. https:\/\/doi.org\/10.1186\/s13052-025-01875-2.","journal-title":"Ital J Pediatr"},{"issue":"1","key":"2040_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/practneurol-2018-001899","volume":"19","author":"DH Whittam","year":"2019","unstructured":"Whittam DH, Tallantyre EC, Jolles S, Huda S, Moots RJ, Kim HJ, et al. Rituximab in neurological disease: principles, evidence and practice. Pract Neurol. 2019;19(1):5\u201320. https:\/\/doi.org\/10.1136\/practneurol-2018-001899.","journal-title":"Pract Neurol"},{"issue":"1","key":"2040_CR22","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1212\/NXI.0000000000000188","volume":"3","author":"M Nosadini","year":"2016","unstructured":"Nosadini M, Alper G, Riney CJ, Benson LA, Mohammad SS, Ramanathan S, et al. Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm. 2016;3(1):e188. https:\/\/doi.org\/10.1212\/NXI.0000000000000188.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"2040_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1212\/WNL.0000000000000570","volume":"83","author":"RC Dale","year":"2014","unstructured":"Dale RC, Brilot F, Duffy LV, Twilt M, Waldman AT, Narula S, et al. Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease. Neurology. 2014;83(2):142\u201350. https:\/\/doi.org\/10.1212\/WNL.0000000000000570.","journal-title":"Neurology"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-026-02040-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-026-02040-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-026-02040-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:10:14Z","timestamp":1786165814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-026-02040-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["2040"],"URL":"https:\/\/doi.org\/10.1007\/s12311-026-02040-z","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"22 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective single-case report was conducted in accordance with the Declaration of Helsinki. Ethical review and approval were not required for this de-identified single case report in accordance with local legislation and institutional requirements.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication of this case report and any accompanying anonymized clinical information and images was obtained from the patient\u2019s legal guardian.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report was prepared in accordance with the CARE reporting guideline.","order":3,"name":"Ethics","label":"Reporting guideline","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"100"}}